Prof. Georg Lenz discusses the recent developments in the treatment of Diffuse Large B-Cell Lymphoma (DLBCL)
Dr Stefan K. Barta discusses recent developments in T-cell lymphoma
A virtual meeting discussing the current and future landscape of treatment for indolent NHL
LYMPHOMA CONNECT has summarised highlights of the recent ASCO 2019 meeting
A review paper ‘Follicular lymphoma: recent and emerging therapies, treatment strategies, and remaining unmet needs’ authored by LYMPHOMA CONNECT members
Dr Brian T. Hill discusses New Molecular Approaches in Diffuse Large B-Cell Lymphoma (DLBCL)
Dr. Tycel J. Phillips discusses the Role of PI3K inhibitors in Non-Hodgkin’s Lymphoma
Dr. Tycel Phillips discusses new agents in diffuse large B-cell lymphoma and follicular lymphoma
Dr. Matthew Matasar provides an update on follicular lymphoma
This comprehensive resource looks at PARP inhibition and DDR as therapeutic targets across multiple tumour types
Authored by LYMPHOMA & MYELOMA CONNECT members, the paper ‘Translating the Biology of Diffuse Large B-cell Lymphoma into Treatment’ provides an overview of recent advances in DLBCL biology and how they can be translated into clinical care.
Dr. Matthew J. Matasar summarises the highlights in lymphoma from ASH 2021, including POLARIX, CAR-T in LBCL and mosunetuzumab in FL
We celebrate our 10-year anniversary at the COR2ED booth during ESMO 2022. In 10 years, 500,000 healthcare professionals have trusted our educational programmes.
COR2ED brings you an update on a selection of late-breaking abstracts presented in the Presidential Symposia at ESMO 2022.
Highlights from the ASH Annual Meeting
Episode 1: Non-Small-Cell Lung Cancer Update: ADAURA trial